Intra-Osseous Access in Difficult Vascular Access Cases
NCT ID: NCT05708833
Last Updated: 2025-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2023-03-02
2024-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Failure or delay in obtaining venous access can be life-threatening. Thus, alternatives to peripheral venous access have been proposed including intraosseous route recently made easier by the development of an automated puncture device (EZ-IO®), but still rarely used, especially on conscious patient.
Currently, the place of intraosseous venous access in critical patients is not determined.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Failure of First-attempt Insertion and Analysis of Practices Related to Peripheral Intravenous Catheters in the Emergency Department:
NCT06851585
Cardiac Arrest and Intra Osseous Infusion
NCT01803971
Safe-Infusion Study
NCT06727240
Continuous Intraosseous Vascular Access Over 48 Hours
NCT01866475
Onyx™ Liquid Embolic IDE Clinical Study
NCT06742801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intraosseous venous access
intraosseous venous access
Intraosseous venous access
Immediate placement of humeral intra-osseous venous access (after a first failed attempt of peripheral venous access)
peripheral venous access
Limiting use of intraosseous access (intraosseous access possible after 3 attempts of peripheral venous access)
Peripheral venous access
Looking for peripheral venous access, changing the site of puncture, the caliber of the catheter and/or the operator and/or assistance tools (ultrasound, infra-red guidance...) and/or using another route (oral, rectal, subcutaneous, intramuscular route and central venous access)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraosseous venous access
Immediate placement of humeral intra-osseous venous access (after a first failed attempt of peripheral venous access)
Peripheral venous access
Looking for peripheral venous access, changing the site of puncture, the caliber of the catheter and/or the operator and/or assistance tools (ultrasound, infra-red guidance...) and/or using another route (oral, rectal, subcutaneous, intramuscular route and central venous access)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient with hemodynamic failure defined as:
* systolic blood pressure (SBP) \< 90 mm Hg (2 measures) or
* cardiac arrest or
3. Any situation requiring intubation
Exclusion Criteria
2- Venous access already available
3- Known contra-indications to intraosseous access (i.e. bilateral lesions):
* Bone fracture
* Skin infection
* Osteoporosis
* Osteomyelitis
* Local burns
* Recent failed intraosseous attempt
* Prior surgery
* Compartment syndrome
* Every other local specific situations
4- Pregnancy woman
5- Patient with no national health or universal plan affiliation coverage
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LAPOSTOLLE Frédéric, PhD MD
Role: PRINCIPAL_INVESTIGATOR
APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Avicenne
Bobigny, France, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P170918J
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.